THE FAUCI FILES, Vol 3(1): Anthrax Vaccine Scandal Unravels, Part I

fred fredshaw at primenet.com
Mon Jan 10 12:23:19 EST 2000


THE FAUCI FILES, Vol 3(1): Anthrax Vaccine Scandal Unravels, Part I
January 3, 2000


Joint Chiefs of Staff Ex-Chairman Admiral Crowe Owns Vaccine Company

In the FDA action involving BioPort, the military?s anthrax 
vaccine plans grind to a halt, as suggestions of yet another 
obnoxious government ethics scandal have become all too familiar:

   ?One of the owners of BioPort is Adm. William Crowe, the 
    retired chairman of the Joint Chiefs of Staff.? 

   ?The Pentagon ... has put a brigadier general in charge of 
    making sure the privately owned company gets its plant 
    approved quickly?

   ?BioPort bought the lab from Michigan Biologic Products 
    Institute for $25 million in 1998, and in the face of 
    bankruptcy, tripled the price of the anthrax vaccine in 
    August, with the Pentagon?s approval. The Defense 
    Department awarded the company an additional $18.7 million 
    for the vaccines it had already purchased.?

   ?The Pentagon is giving BioPort of Lansing, Mich., 
    $7 million to $10 million, on top of the $130 million 
    it already invested...?

No explanation is offered for the BioPort ownership ?interests? 
of Admiral Crowe. However, the human experiment continues, even
though the Anthrax vaccine remains UNAPPROVED by the FDA:

   ?Two years ago, the department (of Defense) began 
    vaccinating soldiers who were being deployed to so-called 
    high-threat areas...?

   ?The military needs about 75,000 doses a month to inoculate 
    soldiers...?

The Anthrax vaccine for the U.S. military has been rather 
controversial since early 1999. While the actual reasons 
for the controversy have not been made clear, it seems 
that media has simply focused on the soldiers who have refused 
their commanding officers? orders to be vaccinated against 
Anthrax in full knowledge that they would be court-martialed.

In another recent report on this subject, the military denied 
the Anthrax vaccine could cause health problems, yet the 
military doctors admitted that they had NOT been monitoring the 
potential for health problems that could result from the 
Anthrax vaccine.

>From the UPI article of December 13, 1999 (below), here are some 
revealing quotes:

   ?The Defense Department had hoped to begin inoculating 
    soldiers early next year, said Dr. Sue Bailey, assistant
    secretary of defense for health affairs.?

   ?Another million doses, dating as far back as 1985, are 
    warehoused but have not been certified for use for various 
    reasons?

?Various reasons?? Hmmm, one must wonder what exact 
contaminants are in those warehoused vaccines, who was harmed 
by them, and who in the government got rich from yet another
scam that endangers the lives of military "lab rats"?

Naturally, since NIH/NIAID?s Dr. Anthony ?Mussolini? Fauci, 
M.D. remains the Direktor of the government agency in charge of 
vaccines and since Fauci is NO STRANGER to these sort of 
scandals, one must wonder about the extent of Fauci?s 
involvement in the Anthrax vaccine scam [NOTE: Fauci?s own 
murderous IL-2 patent scandal as a possible ?HIV cure? lasted a 
decade, squandered millions in tax dollars and killed 
thousands. More recently, Fauci?s patent-pending ?invention? of HIV 
vaccine peptides were shown to INCREASE the risk of HIV 
infection for the vaccinated, rather than prevent infection].

While the military claims that its ?need? for the vaccine is an 
urgent one, yet it does not appear to be in a rush to find an 
alternate supplier, nor does it seem to be interested in using 
the vaccines that have been in storage since 1986. 

Apparently, the crooks in the Defense Department have granted
Admiral Crowe?s vaccine an exclusive -- it will be the Admiral's
vaccine, or it will be no vaccine.

And the best of the worst is yet to come ... so stay tuned 
for Part II !!!

Crooked Murdering Bastards!

fred

====================================
Anthrax Vaccine Maker Fails FDA test

WASHINGTON, Dec. 13 (UPI) -- The Pentagon?s only producer of 
the anthrax vaccine failed its FDA inspection last month, 
impeding the Defense Department?s ability to inoculate soldiers 
if a conflict of the scope of the Persian Gulf War started, 
according to Pentagon officials. 

?We could not today do a full blow-up to (a Desert Storm-size 
conflict) and have every serviceman or woman vaccinated on the 
battlefield,? said Maj. Gen. Randall West, the Pentagon?s 
special adviser on anthrax and biological defense matters. 
Desert Storm required the deployment of more than 500,000 
soldiers. 

The Defense Department had hoped to begin inoculating soldiers 
early next year, said Dr. Sue Bailey, assistant secretary of 
defense for health affairs. 

The Pentagon is giving BioPort of Lansing, Mich., $7 million to 
$10 million, on top of the $130 million it already invested, to 
help correct the problem and has put a brigadier general in 
charge of making sure the privately owned company gets its 
plant approved quickly, said David Oliver, principal deputy 
undersecretary of defense for acquisition. 

One of the owners of BioPort is Adm. William Crowe, the retired 
chairman of the Joint Chiefs of Staff. The plant was hit with 
34 equipment and process-related deficiencies by Food and Drug 
Administration inspectors in November, setting back the 
Pentagon?s hoped-for mass vaccination program by six to 12 
months, said Oliver. There will be a series of follow-up 
inspections that could reveal more problems, Oliver said. 

There is no deadline for attaining certification, Oliver 
explained, because the Defense Department?s foremost concern is 
that the vaccine be both safe and effective. 

Two years ago, the department began vaccinating soldiers who 
were being deployed to so-called high-threat areas: the Persian 
Gulf and South Korea, areas where anthrax spores are believed 
to be packed in weapons by Iraq and North Korea. At any given 
time, there are roughly 23,000 service personnel in the Gulf 
and 37,000 in Korea. 

The military needs about 75,000 doses a month to inoculate 
soldiers deployed to those regions, and those preparing to 
deploy. 

About 383,000 military personnel have received the six-course 
vaccination so far. The Pentagon had hoped to begin the second 
phase of its operation, which involves having enough vaccine on 
hand to immunize hundreds of thousands of soldiers rapidly in 
the event of a major crisis. 

As it stands, the department has about 2 million usable doses?
just enough to continue immunizing soldiers who rotate in and 
out of the Gulf and Korea until BioPort is expected to produce 
viable, safe vaccine. 

The Pentagon is funding BioPort to the tune of about $130 
million to build a state-of-the-art production facility on the 
site of an old Michigan state-run laboratory and expects to 
spend $228 million on the program between fiscal years 2001 and 
2005. Production will burgeon from the old rate of about 2,000 
doses a year to 400,000 a month. 

Another million doses, dating as far back as 1985, are 
warehoused but have not been certified for use for various 
reasons, Oliver said. 

BioPort bought the lab from Michigan Biologic Products 
Institute for $25 million in 1998, and in the face of 
bankruptcy, tripled the price of the anthrax vaccine in August, 
with the Pentagon?s approval. The Defense Department awarded 
the company an additional $18.7 million for the vaccines it had 
already purchased. 

Oliver said he thinks the company will rise to the challenge of 
fixing the new lab?s faults and producing the vaccine in 
sufficient amounts. He said he believes this ?because the 
people are inherently good people.? 

Bailey said the vaccine is the best method of protecting 
soldiers from anthrax, although protective clothing and 
antibiotics are also available.

----------






More information about the Immuno mailing list